TLDR:
Two Bear Capital, a VC firm, appointed five key executives to strengthen its team during a period of rapid growth. The appointments include Bridget Martell as Operating Partner, Biotechnology; Jeff Miller as Operating Partner, Enterprise; Tim Veil as Principal; Kevin Day as Partner, Head of Capital Formation; and Jennifer Howrigan as Vice President of Investor Relations. These executives bring valuable experience from various industries to support Two Bear Capital’s portfolio companies.
Two Bear Capital, a VC firm investing in life sciences and technology disruptors, announced the appointment of five key executives to strengthen its team during a period of rapid growth. These appointments include Bridget Martell as Operating Partner, Biotechnology; Jeff Miller as Operating Partner, Enterprise; Tim Veil as Principal; Kevin Day as Partner, Head of Capital Formation; and Jennifer Howrigan as Vice President of Investor Relations. These appointments aim to enhance the firm’s ability to support its portfolio companies and drive growth.
Bridget Martell will focus on biopharma and health tech portfolio companies, Jeff Miller will work with enterprise portfolio companies, Tim Veil will identify new technology-focused investments, Kevin Day will lead capital formation efforts, and Jennifer Howrigan will manage investor relations. Each executive brings valuable experience and expertise to their respective roles, aiming to support Two Bear Capital’s vision of becoming a top-tier venture capital firm.
